225 related articles for article (PubMed ID: 32510847)
1. Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.
Wilke C; Haas E; Reetz K; Faber J; Garcia-Moreno H; Santana MM; van de Warrenburg B; Hengel H; Lima M; Filla A; Durr A; Melegh B; Masciullo M; Infante J; Giunti P; Neumann M; de Vries J; Pereira de Almeida L; Rakowicz M; Jacobi H; Schüle R; Kaeser SA; Kuhle J; Klockgether T; Schöls L; ; Barro C; Hübener-Schmid J; Synofzik M
EMBO Mol Med; 2020 Jul; 12(7):e11803. PubMed ID: 32510847
[TBL] [Abstract][Full Text] [Related]
2. Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.
Wilke C; Mengel D; Schöls L; Hengel H; Rakowicz M; Klockgether T; Durr A; Filla A; Melegh B; Schüle R; Reetz K; Jacobi H; Synofzik M
Neurology; 2022 May; 98(20):e1985-e1996. PubMed ID: 35264424
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
[TBL] [Abstract][Full Text] [Related]
4. Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3.
Tezenas du Montcel S; Petit E; Olubajo T; Faber J; Lallemant-Dudek P; Bushara K; Perlman S; Subramony SH; Morgan D; Jackman B; Figueroa KP; Pulst SM; Fauret-Amsellem AL; Dufke C; Paulson HL; Öz G; Klockgether T; Durr A; Ashizawa T;
Neurology; 2023 Apr; 100(17):e1836-e1848. PubMed ID: 36797067
[TBL] [Abstract][Full Text] [Related]
5. Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
Garcia-Moreno H; Prudencio M; Thomas-Black G; Solanky N; Jansen-West KR; Hanna Al-Shaikh R; Heslegrave A; Zetterberg H; Santana MM; Pereira de Almeida L; Vasconcelos-Ferreira A; Januário C; Infante J; Faber J; Klockgether T; Reetz K; Raposo M; Ferreira AF; Lima M; Schöls L; Synofzik M; Hübener-Schmid J; Puschmann A; Gorcenco S; Wszolek ZK; Petrucelli L; Giunti P
Eur J Neurol; 2022 Aug; 29(8):2439-2452. PubMed ID: 35478426
[TBL] [Abstract][Full Text] [Related]
6. Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography.
Chen Z; Liao G; Wan N; He Z; Chen D; Tang Z; Long Z; Zou G; Peng L; Wan L; Wang C; Peng H; Shi Y; Tang Y; Li J; Li Y; Long T; Hou X; He L; Qiu R; Chen D; Wang J; Guo J; Shen L; Huang Y; Ashizawa T; Klockgether T; Tang B; Zhou M; Hu S; Jiang H
Mov Disord; 2023 Jun; 38(6):978-989. PubMed ID: 37023261
[TBL] [Abstract][Full Text] [Related]
7. Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3.
Mengel D; Wellik IG; Schuster KH; Jarrah SI; Wacker M; Ashraf NS; Öz G; Synofzik M; Costa MDC; McLoughlin HS
Dis Model Mech; 2023 Sep; 16(9):. PubMed ID: 37664882
[TBL] [Abstract][Full Text] [Related]
8. Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3.
Peng Y; Zhang Y; Chen Z; Peng H; Wan N; Zhang J; Tang J; Wang P; Xie Y; Cai Q; Liu S; Zhang X; Wang C; Yuan H; Li T; Wan L; Shi Y; Qiu R; Klockgether T; Tang B; Liao W; Jiang H
Neurology; 2020 Dec; 95(22):e2977-e2987. PubMed ID: 32817181
[TBL] [Abstract][Full Text] [Related]
9. Progression of Clinical and Eye Movement Markers in Preataxic Carriers of Machado-Joseph Disease.
de Oliveira CM; Leotti VB; Cappelli AH; Rocha AG; Ecco G; Bolzan G; Kersting N; Saraiva-Pereira ML; Jardim LB
Mov Disord; 2023 Jan; 38(1):26-34. PubMed ID: 36129443
[TBL] [Abstract][Full Text] [Related]
10. Towards the Identification of Molecular Biomarkers of Spinocerebellar Ataxia Type 3 (SCA3)/Machado-Joseph Disease (MJD).
Lima M; Raposo M
Adv Exp Med Biol; 2018; 1049():309-319. PubMed ID: 29427111
[TBL] [Abstract][Full Text] [Related]
11. Blood Neurofilament Light Chain in Genetic Ataxia: A Meta-Analysis.
Peng L; Wang S; Chen Z; Peng Y; Wang C; Long Z; Peng H; Shi Y; Hou X; Lei L; Wan L; Liu M; Zou G; Shen L; Xia K; Qiu R; Tang B; Ashizawa T; Klockgether T; Jiang H
Mov Disord; 2022 Jan; 37(1):171-181. PubMed ID: 34519102
[TBL] [Abstract][Full Text] [Related]
12. PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study.
Gonsior K; Kaucher GA; Pelz P; Schumann D; Gansel M; Kuhs S; Klockgether T; Forlani S; Durr A; Hauser S; Rattay TW; Synofzik M; Hengel H; Schöls L; Rieß OH; Hübener-Schmid J
J Neurol; 2021 Apr; 268(4):1304-1315. PubMed ID: 33106888
[TBL] [Abstract][Full Text] [Related]
13. Stage-dependent biomarker changes in spinocerebellar ataxia type 3.
Faber J; Berger M; Carlo W; Hübener-Schmid J; Schaprian T; Santana MM; Grobe-Einsler M; Onder D; Koyak B; Giunti P; Garcia-Moreno H; Gonzalez-Robles C; Lima M; Raposo M; Melo ARV; de Almeida LP; Silva P; Pinto MM; van de Warrenburg BP; van Gaalen J; de Vries J; Jeroen ; Oz G; Joers JM; Synofzik M; Schöls L; Riess O; Infante J; Manrique L; Timmann D; Thieme A; Jacobi H; Reetz K; Dogan I; Onyike C; Povazan M; Schmahmann J; Ratai EM; Schmid M; Klockgether T
medRxiv; 2023 Apr; ():. PubMed ID: 37163081
[TBL] [Abstract][Full Text] [Related]
14. Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study.
Wilke C; Reich S; van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Galimberti D; Rowe JB; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Frisoni G; Ghidoni R; Sorbi S; Bocchetta M; Todd E; Kuhle J; Barro C; ; Rohrer JD; Synofzik M
Ann Neurol; 2022 Jan; 91(1):33-47. PubMed ID: 34743360
[TBL] [Abstract][Full Text] [Related]
15. Association Between Serum Neurofilament Light Chain and Neurochemistry Deficits in Patients with Spinocerebellar Ataxia Type 3.
Chen Y; Jin Y; Hu Z; Qiu M; Li D; Cai Q; Tao C; Lou D; Qi L; Chen S; Yu H; Gao Z
Cerebellum; 2024 Feb; 23(1):92-100. PubMed ID: 36598718
[TBL] [Abstract][Full Text] [Related]
16. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Molecular Signatures of Cerebellar Pathology in Spinocerebellar Ataxia Type 3.
Costa MDC; Radzwion M; McLoughlin HS; Ashraf NS; Fischer S; Shakkottai VG; Maciel P; Paulson HL; Öz G
Mov Disord; 2020 Oct; 35(10):1774-1786. PubMed ID: 32621646
[TBL] [Abstract][Full Text] [Related]
18. Pre-ataxic Changes of Clinical Scales and Eye Movement in Machado-Joseph Disease: BIGPRO Study.
de Oliveira CM; Leotti VB; Bolzan G; Cappelli AH; Rocha AG; Ecco G; Kersting N; Rieck M; Martins AC; Sena LS; Saraiva-Pereira ML; Jardim LB
Mov Disord; 2021 Apr; 36(4):985-994. PubMed ID: 33438269
[TBL] [Abstract][Full Text] [Related]
19. Blood neurofilament light chain levels are associated with disease progression in a transgenic SCA3 mouse model.
Mengel D; Wellik IG; Schuster KH; Jarrah SI; Wacker M; Ashraf NS; Öz G; Synofzik M; do Carmo Costa M; McLoughlin HS
bioRxiv; 2023 Mar; ():. PubMed ID: 36909535
[TBL] [Abstract][Full Text] [Related]
20. NfL and pNfH are increased in Friedreich's ataxia.
Hayer SN; Liepelt I; Barro C; Wilke C; Kuhle J; Martus P; Schöls L;
J Neurol; 2020 May; 267(5):1420-1430. PubMed ID: 32002649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
